At a glance
ClinicalIndex Comparison RecordN/ACompleted· 373 enrolled
Drug / intervention
The Raindrop Near Vision Inlaydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multinational Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ReVision Optics, Inc. PresbyLens Corneal Inlay for the Improvement of Near Vision in Presbyopic Subjects With MRSE From -0.50 to +1.00
In Brief
A clinical study evaluating The Raindrop Near Vision Inlay for Presbyopia. Completed, enrolled 373 participants across 11 sites.
Detailed Summary
This study will be a prospective, multicenter clinical trial in which a total of 400 subjects will be enrolled. All subjects will be followed over a 36 month time frame with a maximum of 15 clinical sites participating. Qualified subjects will provide informed consent for entry into the study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2010
First PostedJun 2011
Primary CompletionDec 2016
TodayJul 2026
First PostedJun 15, 2011
Enrollment StartApr 1, 2010
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6.7 yearsPosted 15.0 years ago
Interventions
The Raindrop Near Vision Inlaydevice
The Raindrop Near Vision Inlay is implanted in the cornea for treatment of presbyopia